content top

Vitrectomy for Non Tractional DME: Is It Worth?

ABSTRACT Some years ago, the option of PPV as a therapeutic approach to DME was popular, but it is now outdated: intravitreal injections are the standard of care. But being outdated, doesn’t mean being useless. There is no doubt that the aim of whatever therapy we decide to try for VASCULAR edema must target the neuroinflammation that is the cause of it, but this is not the point. The Qs are two: Can vitrectomy be used as an...

Read More

Surgery for Myopic Traction Maculopathy: Tamponade is Unnecessary

ABSTRACT Myopic Traction Maculopathy is a tractional disease, and the only purpose of vitrectomy is to release traction. This traction is most often hidden under vitreoretinal adhesions, or almost invisible due to the sub atrophic aspect of RPE. After traction release, there’s no need for tamponade, that may also result dangerous for the retina. Slowly the retina will reassume the normal aspect and also visual acuity can be partially...

Read More

Myopic Traction Maculopathy: Follow-up and Treatment

Myopic Traction Maculopathy: Follow-up and Treatment ABSTRACT Principles regulating manifestations and progression of MTM will be discussed, together with the personal surgical approach. CONTACT DETAILS Giacomo Panozzo Verona, Italy Email : g.panozzo@iol.it Cell Phone: +393483365239 Work Phone:...

Read More

DME Progression After Cataract Surgery: An Underestimated But Very Frequent Complication

DME Progression After Cataract Surgery: An Underestimated But Very Frequent Complication ABSTRACT DME can develop or worsen after cataract surgery in diabetic eyes, even in the absence of mild or advanced retinopathy, and in up to 56% of cases. Surgeons must be aware of this dramatic complication, that can easily and permanently vanish the potential benefit of surgery. CONTACT DETAILS Giacomo Panozzo Verona, Italy Email :...

Read More

Myopic Traction Maculopathy: A Slowly Progressive and Treatable Disease

http://www.evrs.eu/medias/2006/congress/Myopic-Traction-Maculopathy:-A-Slowly-Progressive-and-Treatable-Disease.swf Giacomo Panozzo, MD (Verona, Italy), Barbara Parolini, MD (Verona, Italy), Andrea Mercanti, MD (Verona, Italy) PURPOSE: Myopic Traction Maculopathy (MTM) is a recently discovered cause of visual impairment in high myopia, generated by the presence of anomalous vitreoretinal traction inside the staphyloma. Development, natural...

Read More

Vitrectomy for Diabetic Macular Edema: Study Design and Preliminary Results of VIDE Study, an Italian Clinical Trial

http://www.evrs.eu/medias/2006/congress/Vitrectomy-for-Diabetic-Macular-Edema:-Study-Design-and-Preliminary-Results-of-VIDE-Study,-an-Italian-Clinical-Trial.swf Barbara Parolini, MD (Verona, Italy), Giacomo Panozzo, MD (Verona, Italy), Fabio Patelli, MD (Milan, Italy) PURPOSE: This is a three-centers prospective clinical trial on diffuse, non-tractional diabetic macular edema comparing the effects of simple vitrectomy (core PPV with PVD...

Read More

Vitrectomy versus Natural History for Non-Tractional Diabetic Macular Edema (DME): the Vide Study

Giacomo Panozzo – for the Vide Study Group Purpose: The purpose of the study is to better understand the natural history of diffuse diabetic macular edema, and to compare it with the efficacy of simple vitrectomy. Methods: Patients will be recruited until September 2005, and will be followed for one year, using as main outcomes quantitative and qualitative analisys of macular function (VA by ETDRS charts, FA and OCT, microperimetry and...

Read More
content top